{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:58:49Z","timestamp":1777877929585,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"abstract":"<jats:p>\n                    The purpose of this study was to investigate the relationships between serum biomarkers Orexin A, PBP4, FGF19, and insulin resistance as measured by HOMA-IR, and neonatal weight in patients with gestational diabetes mellitus (GDM). A total of 80 pregnant women diagnosed with GDM were enrolled in this cross-sectional study. Baseline characteristics, including age, body mass index (BMI), and gestational age, were recorded. Fasting blood samples were collected to assess serum levels of Orexin A, PBP4, and FGF19, as well as to calculate HOMA-IR as a measure of insulin resistance. Neonatal birth weight was documented at delivery. Statistical analyses included Pearson correlation, multivariate linear regression, and subgroup analysis based on median values of HOMA-IR and neonatal birth weight. A statistically significant positive correlation was observed between insulin resistance, and neonatal birth weight (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    \u2005=\u20050.45,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The low HOMA-IR group has significantly higher levels of Orexin A, PBP4, and FGF19 compared to the high HOMA-IR group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    -values: .02, .04, and .01, respectively), indicating a negative association with insulin resistance. Orexin A, PBP4 and FGF19 are negatively associated with both insulin resistance (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03) and birth weight (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02). Furthermore, a moderation effect of BMI on the relationship between PBP4 levels and insulin resistance, with stronger associations observed in women with a higher BMI. The study reveals that serum Orexin A, PBP4, and FGF19 are significantly associated with insulin resistance and neonatal weight in GDM, with BMI modulating the impact of PBP4 on insulin resistance. These biomarkers could serve as predictive indicators for insulin resistance and fetal growth in GDM, suggesting potential mechanism of insulin resistance affecting newborn weight.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044040","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T21:01:27Z","timestamp":1756846887000},"page":"e44040","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Correlation analysis of serum Orexin A, PBP4, and FGF19 levels with insulin resistance and neonatal weight in gestational diabetes mellitus: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3020-6159","authenticated-orcid":false,"given":"Xiaojie","family":"Jia","sequence":"first","affiliation":[{"name":"Obstetrical Department, Shenzhen Futian District Maternal and Child Health Hospital, Shenzhen, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260430","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"R2-20260430","first-page":"1248","article-title":"Association between probiotic yogurt intake and gestational diabetes mellitus: a case-control study.","volume":"48","author":"Chen","year":"2019","journal-title":"Iran J Public Health"},{"key":"R3-20260430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12884-020-2759-8","article-title":"Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia.","volume":"20","author":"Muche","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"R4-20260430","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/jocn.15959","article-title":"Risk factors for women with gestational diabetes mellitus developing type 2 diabetes and the impact on children\u2019s health.","volume":"31","author":"Chiou","year":"2022","journal-title":"J Clin Nurs"},{"key":"R5-20260430","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2298\/MPNS2108238I","article-title":"Appropriate use of the homeostasis model assessment of insulin resistance indices.","volume":"74","author":"Ivanov","year":"2024","journal-title":"Med Pregl"},{"key":"R6-20260430","doi-asserted-by":"crossref","first-page":"779","DOI":"10.24996\/ijs.2021.62.3.8","article-title":"Relationship between Orexin-A and insulin resistance in patients with Type 2 diabetes mellitus.","volume":"3","author":"Sadiq","year":"2021","journal-title":"Iraqi J Sci"},{"key":"R7-20260430","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.numecd.2014.05.007","article-title":"The association between apolipoprotein M and insulin resistance varies with country of birth.","volume":"24","author":"Memon","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R8-20260430","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.placenta.2021.07.286","article-title":"FGF15\/FGF19 alleviates insulin resistance and upregulates placental IRS1\/GLUT expression in pregnant mice fed a high-fat diet.","volume":"112","author":"Zhao","year":"2021","journal-title":"Placenta"},{"key":"R9-20260430","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12884-020-03157-7","article-title":"The combination of symphysis-fundal height and abdominal circumference as a novel predictor of macrosomia in GDM and normal pregnancy.","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"R10-20260430","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2018.09.003","article-title":"In utero exposure to gestational diabetes mellitus and long term endocrine morbidity of the offspring.","volume":"144","author":"Abokaf","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"R11-20260430","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1507\/endocrj.EJ12-0030","article-title":"Role of orexin in the central regulation of glucose and energy homeostasis.","volume":"59","author":"Tsuneki","year":"2012","journal-title":"Endocr J"},{"key":"R12-20260430","doi-asserted-by":"crossref","first-page":"e3229","DOI":"10.1002\/dmrr.3229","article-title":"Hypocretin\/orexin modulates body weight and the metabolism of glucose and insulin.","volume":"36","author":"Adeghate","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"R13-20260430","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/db14-0695","article-title":"Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice.","volume":"64","author":"Tsuneki","year":"2015","journal-title":"Diabetes"},{"key":"R14-20260430","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by apolipoprotein M\/Sphingosine-1-phosphate.","volume":"69","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"R15-20260430","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1871530319666191023125820","article-title":"Insulin resistance in apolipoprotein M knockout mice is mediated by the protein kinase Akt signaling pathway.","volume":"20","author":"Yao","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R16-20260430","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/jdi.13261","article-title":"Apolipoprotein M overexpression through adeno-associated virus gene transfer improves insulin secretion and insulin sensitivity in Goto-Kakizaki rats.","volume":"11","author":"Yu","year":"2020","journal-title":"J Diabetes Investig"},{"key":"R17-20260430","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13098-019-0475-1","article-title":"Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients.","volume":"11","author":"Tang","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"R18-20260430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsbmb.2012.04.008","article-title":"Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.","volume":"132","author":"Miyata","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-20260430","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1447-0756.2012.01955.x","article-title":"Maternal and fetal serum orexin-A levels in gestational diabetes mellitus.","volume":"39","author":"Yilmaz","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"R20-20260430","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jnutbio.2004.03.001","article-title":"Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.","volume":"15","author":"Xu","year":"2004","journal-title":"J Nutr Biochem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:06:23Z","timestamp":1777590383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":20,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044040","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}